Tenaya Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Tenaya Therapeutics, Inc. (TNYA) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 41.30 million shares for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-08-10
- Tenaya Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-06-30 was 41.30M shares, a 3499.41% increase year-over-year.
- Tenaya Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 41.27M shares, a 3659.14% increase year-over-year.
- Tenaya Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 41.51M shares, a 3863.59% increase year-over-year.
- Tenaya Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 26.90M shares, a 2589.43% increase year-over-year.
- Tenaya Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 17.73M shares, a 1724.33% increase from fiscal 2020.
- Tenaya Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 972.09K shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-06-30 | 41.30M shares 10-Q · filed 2022-08-10 | 41.29M shares 10-Q · filed 2022-08-10 | 41.36M shares derived: average of 3 quarters · filed 2022-08-10 | 37.74M shares derived: average of 4 quarters · filed 2022-08-10 |
| 2022-03-31 | 41.27M shares 10-Q · filed 2022-05-11 | 41.39M shares derived: average of 2 quarters · filed 2022-05-11 | 36.56M shares derived: average of 3 quarters · filed 2022-05-11 | 27.71M shares derived: average of 4 quarters · filed 2022-08-10 |
| 2021-12-31 | 41.51M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | 34.20M shares derived: average of 2 quarters · filed 2022-03-23 | 23.19M shares derived: average of 3 quarters · filed 2022-08-10 | 17.73M shares 10-K · filed 2022-03-23 |
| 2021-09-30 | 26.90M shares 10-Q · filed 2021-11-10 | 14.02M shares derived: average of 2 quarters · filed 2022-08-10 | 9.81M shares 10-Q · filed 2021-11-10 | 7.55M shares derived: average of 4 quarters · filed 2022-08-10 |
| 2021-06-30 | 1.15M shares 10-Q · filed 2022-08-10 | 1.12M shares 10-Q · filed 2022-08-10 | 1.10M shares derived: average of 3 quarters · filed 2022-08-10 | 1.07M shares derived: average of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | 1.10M shares 10-Q · filed 2022-05-11 | 1.07M shares derived: average of 2 quarters · filed 2022-05-11 | 1.05M shares derived: average of 3 quarters · filed 2022-05-11 | 1.02M shares derived: average of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | 1.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | 1.02M shares derived: average of 2 quarters · filed 2022-03-23 | 998.60K shares derived: average of 3 quarters · filed 2022-03-23 | 972.09K shares 10-K · filed 2022-03-23 |
| 2020-09-30 | 1.00M shares 10-Q · filed 2021-11-10 | 974.23K shares derived: average of 2 quarters · filed 2021-11-10 | 947.01K shares 10-Q · filed 2021-11-10 | |
| 2020-06-30 | 948.40K shares 10-Q · filed 2021-09-08 | 920.20K shares 10-Q · filed 2021-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |